Skip to content

Comparison of Morphine and Dexmedetomidine with spinal anaesthesia drug bupivacaine on duration of pain free period.

Comparison of Morphine Versus Dexmedetomidine as Adjuvant to Intrathecal Hyperbaric Bupivacaine on the Duration of Anaesthesia in Infraumbilical Surgeries - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063905
Enrollment
80
Registered
2024-03-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: MORPHINE: 15mg hyperbaric bupivacaine 0.5% with 150mcg morphine will be given intrathecally in patients undergoing infraumbilical surgeries. Patients will be observed for 12 hours post

Sponsors

Dr Santhosh M C B
Lead Sponsor
Dr Varun N S
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists(ASA) Physical Status Grade I and Grade II patients. Patients within BMI range of 18.5kg - 24.9 Patients willing to give informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Patients on long term treatment with any opioids and a2 agonist Patients taking a receptor antagonists, calcium channel blockers, angiotensin converting enzyme inhibitors or on any kind of analgesics Patients who are pregnant.

Design outcomes

Primary

MeasureTime frame
To compare the sensory and motor characteristics between morphine and dexmedetomidine as adjuvant to intrathecal 0.5% hyperbaric bupivacaine in spinal anaesthesia for infraumbilical surgeries.Timepoint: 12 hours

Secondary

MeasureTime frame
To compare cardiorespiratory changes between the groups To compare adverse events between the groupsTimepoint: 12 hours

Countries

India

Contacts

Public ContactDr Santhosh M C B

Mandya Institute of Medical Sciences

mcbsanthu@gmail.com7892877646

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026